Sanofi, 82, Avenue Raspail, 94250 Gentilly, France.
CIC INSERM 1405/Plateforme d'Investigation Clinique CHU Gabriel Montpied, 58 Rue Montalembert, CEDEX 1, 63000 Clermont-Ferrand, France.
Nutrients. 2022 Apr 29;14(9):1863. doi: 10.3390/nu14091863.
The effect of a combination of magnesium, vitamins B6, B9, B12, rhodiola and green tea/L-theanine (Mg-Teadiola) on stress was evaluated in chronically stressed, otherwise healthy individuals. Effects on stress-related quality-of-life parameters (sleep and perception of pain) were also explored. Adults with stress for ≥1 month, scoring ≥14 points on the Depression Anxiety Stress Scale (DASS)-42 questionnaire, were randomized (1:1) to receive oral Mg-Teadiola (n = 49) or a placebo (n = 51), for 28 days, with a follow-up assessment on Day 56 (NCT04391452). The primary endpoint was the change in the DASS-42 stress score from baseline to Day 28 with Mg-Teadiola versus placebo. The DASS-42 stress scores significantly decreased from baseline to Day 28 with Mg-Teadiola versus placebo (effect size, 0.29; 95% CI [0.01, 0.57]; p = 0.04). Similar reductions were observed on Day 14 (p = 0.006) and Day 56 (p = 0.02). A significant reduction in sensitivity to cold pain (p = 0.01) and a trend for lower sensitivity to warm pain was observed (p = 0.06) on Day 28. Improvements in daytime dysfunction due to sleepiness (Pittsburgh Sleep Quality Index-7 component score) were reported on Day 28, and were significant on Day 56 (p < 0.001). Mg-Teadiola is effective in managing stress in otherwise healthy individuals. Its beneficial effects on sleep and pain perception need further investigation.
在患有慢性压力且健康状况良好的个体中,评估了镁、维生素 B6、B9、B12、红景天和绿茶/L-茶氨酸(Mg-Teadiola)联合使用对压力的影响。还探讨了对与压力相关的生活质量参数(睡眠和疼痛感知)的影响。具有≥1 个月压力、抑郁焦虑压力量表(DASS-42)问卷得分≥14 分的成年人按 1:1 随机分为口服 Mg-Teadiola(n = 49)或安慰剂(n = 51)组,共 28 天,随访评估 56 天(NCT04391452)。主要终点是 Mg-Teadiola 与安慰剂相比,DASS-42 压力评分从基线到第 28 天的变化。与安慰剂相比,Mg-Teadiola 组 DASS-42 压力评分从基线到第 28 天显著降低(效应大小,0.29;95%CI[0.01,0.57];p = 0.04)。在第 14 天(p = 0.006)和第 56 天(p = 0.02)也观察到类似的降低。在第 28 天,冷痛敏感度显著降低(p = 0.01),温痛敏感度呈下降趋势(p = 0.06)。第 28 天报告了因嗜睡导致的日间功能障碍(匹兹堡睡眠质量指数-7 成分评分)的改善,第 56 天具有统计学意义(p < 0.001)。Mg-Teadiola 可有效治疗健康个体的压力。它对睡眠和疼痛感知的有益作用需要进一步研究。